Jonathan J. Hodgins

Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade

Joy Hsu, Jonathan J. Hodgins, Malvika Marathe et al. · Journal of Clinical Investigation · 2018 · 796 citations · Full text

Immunology, Nk Cells, Immunologic Mechanism +17

When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancer

Mohamed S. Hasim, Marie Marotel, Jonathan J. Hodgins et al. · Science Advances · 2022 · 92 citations · Full text

Induction of a distinct macrophage population and protection from lung injury and fibrosis by Notch2 blockade

Mayra Cruz Tleugabulova, Sandra P. Melo, Aaron K. Wong et al. · Nature Communications · 2024 · 23 citations · Full text

CEACAM1 is a direct SOX10 target and inhibits melanoma immune infiltration and stemness

John Abou‐Hamad, Jonathan J. Hodgins, Christiano Tanese de Souza et al. · iScience · 2022 · 20 citations · Full text

Loss of the Ste20-like kinase induces a basal/stem-like phenotype in HER2-positive breast cancers

Khalid N. Al‐Zahrani, John Abou‐Hamad, David P. Cook et al. · Oncogene · 2020 · 16 citations

Tumor Biology, Lineage Plasticity, Breast Oncology +11